Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symproic Tablets 0.2 mg Drug Use-Results Survey
jRCT1080223931Recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of naldemedine in opioid-induced constipation (OIC), sponsored by Shionogi & Co., Ltd. Started Jun 2018; status: recruiting.
02
Drugs
naldemedine
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on jRCT1080223931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223931.